A proton beam therapy system dedicated to spot-scanning increases accuracy with moving tumors by real-time imaging and gating and reduces equipment size

A proton beam therapy (PBT) system has been designed which dedicates to spot-scanning and has a gating function employing the fluoroscopy-based real-time-imaging of internal fiducial markers near tumors. The dose distribution and treatment time of the newly designed real-time-image gated, spot-scann...

Full description

Saved in:
Bibliographic Details
Published in:PloS one Vol. 9; no. 4; p. e94971
Main Authors: Shimizu, Shinichi, Miyamoto, Naoki, Matsuura, Taeko, Fujii, Yusuke, Umezawa, Masumi, Umegaki, Kikuo, Hiramoto, Kazuo, Shirato, Hiroki
Format: Journal Article
Language:English
Published: United States Public Library of Science 01-04-2014
Public Library of Science (PLoS)
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A proton beam therapy (PBT) system has been designed which dedicates to spot-scanning and has a gating function employing the fluoroscopy-based real-time-imaging of internal fiducial markers near tumors. The dose distribution and treatment time of the newly designed real-time-image gated, spot-scanning proton beam therapy (RGPT) were compared with free-breathing spot-scanning proton beam therapy (FBPT) in a simulation. In-house simulation tools and treatment planning system VQA (Hitachi, Ltd., Japan) were used for estimating the dose distribution and treatment time. Simulations were performed for 48 motion parameters (including 8 respiratory patterns and 6 initial breathing timings) on CT data from two patients, A and B, with hepatocellular carcinoma and with clinical target volumes 14.6 cc and 63.1 cc. The respiratory patterns were derived from the actual trajectory of internal fiducial markers taken in X-ray real-time tumor-tracking radiotherapy (RTRT). With FBPT, 9/48 motion parameters achieved the criteria of successful delivery for patient A and 0/48 for B. With RGPT 48/48 and 42/48 achieved the criteria. Compared with FBPT, the mean liver dose was smaller with RGPT with statistical significance (p<0.001); it decreased from 27% to 13% and 28% to 23% of the prescribed doses for patients A and B, respectively. The relative lengthening of treatment time to administer 3 Gy (RBE) was estimated to be 1.22 (RGPT/FBPT: 138 s/113 s) and 1.72 (207 s/120 s) for patients A and B, respectively. This simulation study demonstrated that the RGPT was able to improve the dose distribution markedly for moving tumors without very large treatment time extension. The proton beam therapy system dedicated to spot-scanning with a gating function for real-time imaging increases accuracy with moving tumors and reduces the physical size, and subsequently the cost of the equipment as well as of the building housing the equipment.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Competing Interests: The following is the patent relating to material pertinent to this article: “Moving body pursuit irradiating device and positioning method using this device”; Number: US6307914 B1; Issue Date: 2001-10-23; Inventors: Tatsuya Kunieda, Hiroki Shirato. Yusuke Fujii, Masumi Umezawa, and Kazuo Hiramoto are the permanent employees of Hitachi, Ltd. Their affiliation is as follows: Yusuke Fujii Hitachi, Ltd., Hitachi Research Laboratory. Masumi Umezawa Hitachi, Ltd., Hitachi Research Laboratory. Kazuo Hiramoto Hitachi, Ltd., Research & Development Group. The authors declare this does not alter their adherence to PLOS ONE policies on sharing data and materials.
Conceived and designed the experiments: MU KU KH HS. Analyzed the data: SS NM TM. Contributed reagents/materials/analysis tools: SS NM YF. Wrote the paper: TM HS.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0094971